green league
13.8K posts





At ImmunityBio, we continue to prioritize long-term growth and the advancement of our broader immunotherapy platform. This additional non-dilutive financing supports our effort to expand globally with the goal of improving outcomes for patients. Read more: immunitybio.com/immunitybio-st…




$IBRX holding green while the broader market bleeds tells you a lot. After the FDA scare, the easy trade was lower. Instead, this thing keeps absorbing pressure while global approvals, NCCN inclusion, Saudi expansion talk, and new trial data keep stacking in the background. That is not how broken stories trade. That is how stronger hands quietly take control.

Don't miss @fundstrat's Tom Lee live on @CNBCClosingBell with @ScottWapnerCNBC at 3:35pm ET🔔



















